Dr. Paczesny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1044 W. Walnut Street
R4-425
Indianapolis, IN 46202Phone+1 317-278-5487
Summary
- Dr. Sophie Paczesny is a pediatric hematologist/oncologist in Indianapolis, IN. She received her medical degree from University of Paris VII Faculty of Medicine and has been in practice 21 years. She specializes in cancer genetics/cancer risk assessment and pediatric hematologic oncology.
Education & Training
- University of Paris VII Faculty of MedicineClass of 1995
Clinical Trials
- Bridging Pediatric and Adult Biomarkers in Graft-Versus-Host Disease Start of enrollment: 2014 Jan 01
- Sinusoidal Obstruction Syndrome for Stem Cell Transplant Patients Biomarker Study Start of enrollment: 2017 Apr 01
Publications & Presentations
PubMed
- 68 citationsNational Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.Daniel Wolff, Vedran Radojcic, Robert Lafyatis, Resat Cinar, Rachel K. Rosenstein
Transplantation and Cellular Therapy. 2021-10-01 - 22 citationsNational Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention W...Kirsten M. Williams, Yoshihiro Inamoto, Annie Im, Betty K. Hamilton, John Koreth
Transplantation and Cellular Therapy. 2021-06-01 - 8 citationsImmunotherapy through T-cell receptor gene transfer induces severe graft-versus-host diseaseJames L.M. Ferrara, Pavan Reddy, Sophie Paczesny
Immunotherapy. 2010-11-22
Journal Articles
- Upper Gastrointestinal Acute Graft-Versus-Host Disease Adds Minimal Prognostic Value in Isolation or with Other Graft-Versus-Host Disease Symptoms as Currently Diagnos...Margaret MacMillan, Sophie Paczesny, Ran Reshef, Daniel Weisdorf, Haematologica
- From Proteomics to Discovery of First-in-Class ST2 Inhibitors Active in VivoSophie Paczesny, MD, The Journal of Clinical Investigation
Press Mentions
- Risk Biomarkers May Be Used to Anticipate Severe Stem Cell Transplant Adverse Effects: ResearchMay 28th, 2023
- Risk Biomarkers Could Predict Serious Side Effect of Stem Cell TransplantMay 22nd, 2023
- Golden Appointed to Diversity, Inclusion and Equity CommitteeMarch 29th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: